- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Hyperion Therapeutics Inc
+ Add to WatchlistHPTX:US
20.7600 USD 0.1000 0.48%As of 10:33:21 ET on 06/19/2013.
Snapshot for Hyperion Therapeutics Inc (HPTX)
| Open: | 20.7200 | Day's Range: | 20.4500 - 20.9100 | Volume: | 10,647 |
|---|---|---|---|---|---|
| Previous Close: | 20.6600 | 52wk Range: | 9.9500 - 26.5000 | 1-Yr Rtn: | - |
Key Statistics for HPTX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -3.9657 |
| Est. EPS (USD) (12/2013) | -0.7870 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 416.07 |
| Shares Outstanding (M) | 20.04 |
| 30 Day Average Volume | 94,371 |
| Price/Book (mrq) | 4.6296 |
| Price/Sale (ttm) | 460.4544 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/05/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HPTX
Company Profile & Key Executives for HPTX
Hyperion Therapeutics Inc. manufactures pharmaceutical products. The Company focus on developing and marketing of specialty pharmaceutical products for the treatment of gastroenterology and hepatology.
| James I Healy "Jim"Chairman | Donald J SantelChief Executive Officer |
| Jeffrey S FarrowChief Financial Officer | Bruce F ScharschmidtSenior VP/Chief Medical Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
HPTX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page